Your browser doesn't support javascript.
loading
Physician and Pharmacist: Attitudes, Facilitators, and Barriers to Prescribing Naloxone for Home Rescue.
Martino, Janine G; Smith, Shawn R; Rafie, Sally; Rafie, Samantha; Marienfeld, Carla.
Afiliación
  • Martino JG; Department of Pharmacy, University of California San Diego Health, San Diego, California.
  • Smith SR; Department of Pharmacy Practice and Administration, Western University of Health Sciences College of Pharmacy, Pomona, California.
  • Rafie S; Department of Pharmacy, University of California San Diego Health, San Diego, California.
  • Rafie S; Department of Psychiatry, University of California San Diego Health, San Diego, California.
  • Marienfeld C; Department of Mental Health, VA San Diego Healthcare System, San Diego, California.
Am J Addict ; 29(1): 65-72, 2020 01.
Article en En | MEDLINE | ID: mdl-31804746
ABSTRACT
BACKGROUND AND

OBJECTIVES:

We implemented a naloxone education and distribution program in our academic health system. Despite the program, naloxone prescribing was not fully realized. This study aimed to identify the barriers to prescribing.

METHODS:

We conducted a prospective, cross-sectional, mixed-methods study of naloxone prescribers. Participants completed a questionnaire regarding their prescribing practices, attitudes, facilitators, and barriers to prescribing naloxone. Participants were then invited for an interview to further explore these topics and elicit more in-depth explanations.

RESULTS:

Sixty-four physicians and eight pharmacists completed the questionnaire (n = 72). The most commonly reported barrier to prescribing naloxone was time constraints (33%). During the interviews, 14 subthemes emerged within four themes provider competency, provider beliefs, health care system, and patient factors/social climate.

DISCUSSION:

Prescribers identified barriers to naloxone prescribing despite implementation of an institutional overdose education and naloxone distribution (OEND) program. The results were similar to those previously reported prior to initiation of such programs.

CONCLUSION:

In this study, we examined barriers and facilitators to naloxone prescribing. Although previous studies have shown that health care providers endorsed similar barriers, our study indicates that some of those barriers persist despite a concerted effort to educate and promote prescribing via an OEND. While our study is limited by a small, selective sample size the results indicate that improvements to our OEND program are warranted. SCIENTIFIC

SIGNIFICANCE:

Our study addressed an unexplored area of OEND research and may inform future program development. (Am J Addict 2019;0000-00).
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Farmacéuticos / Médicos / Conocimientos, Actitudes y Práctica en Salud Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Am J Addict Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Farmacéuticos / Médicos / Conocimientos, Actitudes y Práctica en Salud Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Am J Addict Asunto de la revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Año: 2020 Tipo del documento: Article